FDA Grants Priority Review to AstraZeneca and Daiichi Sankyo’s Enhertu for First-Line HER2-Positive Metastatic Breast Cancer Read more
Sanofi Boosts Sanofi Ventures with $625M to Accelerate Biotech and Digital Health Investments Read more
Roche’s Giredestrant Shows Significant Progression-Free Survival Benefit in Phase III ER-Positive Breast Cancer Trial Read more
FDA Grants Breakthrough Therapy Designation to Raludotatug Deruxtecan for CDH6-Positive Platinum-Resistant Ovarian and Related Cancers Read more